A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine.

Race, E; Stein, C A; Wigg, M D; Baksh, A; Addawe, M; Frezza, P; Oxford, J S

Race, E; Stein, C A; Wigg, M D; Baksh, A; Addawe, M; Frezza, P; Oxford, J S.

Affiliation

Race E; Department of Academic Virology, London Hospital Medical College, UK.

Vaccine ; 13(16): 1567-75, 1995 Nov.

Article in En | MEDLINE | ID: mdl-8578844

Subject(s)

AIDS Vaccines/pharmacology; Aziridines/pharmacology; HIV-1/drug effects; HIV-1/immunology; Propiolactone/pharmacology; DNA, Viral/drug effects; Enzyme-Linked Immunosorbent Assay; HIV Antigens/analysis; HIV Antigens/immunology; HIV Core Protein p24/analysis; HIV Core Protein p24/immunology; HIV Envelope Protein gp120/analysis; HIV Envelope Protein gp120/immunology; HIV Envelope Protein gp120/pharmacology; HIV-1/growth & development; Humans; Vaccines, Inactivated/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Propiolactone / Aziridines / HIV-1 / AIDS Vaccines Limits: Humans Language: En Journal: Vaccine Year: 1995 Document type: Article Affiliation country: United kingdom Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links